Navigation Links
Covance Inc. Invites You to Join the Webcast of Its First Quarter 2009 Financial Results Conference Call
Date:4/3/2009

PRINCETON, N.J., April 3 /PRNewswire-FirstCall/ -- In conjunction with its first quarter 2009 earnings release (expected to be issued after market close on April 29, 2009), Covance Inc. (NYSE: CVD) is pleased to invite you to listen to its quarterly investor conference call that will be broadcast live over the Internet on Thursday, April 30, 2009 at 9:00 a.m. ET.

    What:  Covance First Quarter 2009 Earnings Webcast and Slide Presentation
    When:  April 30, 2009, 9:00 a.m. ET*
    Where:http://www.covance.com

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.7 billion, global operations in more than 25 countries, and more than 9,600 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at www.covance.com.

*If you are unable to participate during the live webcast, the event will be archived on the web site http://www.covance.com for 14 days.


'/>"/>
SOURCE Covance Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Covance Experts to Present Key Insights on Risk Management at Bio/Pharmaceutical Drug Safety Forum
2. Covance to Present at the Barclays Capital Global Healthcare Conference
3. Covance Elects Bradley T. Sheares to Companys Board of Directors
4. Covance to Present at the 2009 UBS Global Healthcare Services Conference
5. Covance Opens Three New Offices in Ukraine, Slovakia, and Israel
6. Covance Reports Fourth Quarter and Full-Year 2008 Results
7. Covance to Present at the 27th Annual J.P. Morgan Healthcare Conference
8. Covance Inc. Invites You to Join the Webcast of Its Fourth Quarter 2008 Financial Results Conference Call
9. Covance Inc. Invites You to Join the Webcast of Its 2009 Guidance Conference Call
10. Covance to Present at the Credit Suisse 2008 Healthcare Conference
11. Covance and Lilly Enter Into a Strategic R&D Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab Physical Therapy (PRPT) ... preferred physical therapy provider for Derby City CrossFit, effective immediately. , In addition ... quickly and effectively as possible, ProRehab’s sports physical therapists will work with athletes ...
(Date:4/25/2017)... ... April 25, 2017 , ... A ... student test score performance for the 2015-16 school year across Wisconsin’s public schools, ... Though it highlights important patterns in student test score performance, the report’s limited ...
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical ... partners to help with process innovation in drug formulation and manufacturing. CoreRx ... with state-of-the-art analytical equipment in support of their development and manufacturing goals. ...
(Date:4/25/2017)... ... ... MD is committed to providing the highest quality of spine care to all his patients. ... all my patients to alleviate possible future issues. I am pleased to have you as ... my trained staff will assist you in any way possible.” , Dr. Saad Chaudhary is ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... the Urology, Uro/Gyn and Gynecology markets with innovative ... has joined the Company as Senior Vice President, ... position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has joined ...
(Date:4/20/2017)... 2017 Research and Markets has announced the ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ... ... will rise from USD 20 Billion in 2015 to around USD ... Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing ...
(Date:4/20/2017)... Eyevensys, a private biotechnology company ... expression technology that enables the safe, local, sustained production ... wide range of ophthalmic diseases, announces it has received ... Agency (MHRA) to advance its technology into clinical development. ... The EyeCET ...
Breaking Medicine Technology: